貝因美(002570.SZ):控股股東申請預重整
格隆匯7月17日丨貝因美(002570.SZ)公佈,截至本公告披露日,公司控股股東浙江小貝大美控股有限公司(簡稱“小貝大美控股”)共持有公司股份132,629,471股,佔公司總股本的12.28%。其中,被質押或凍結的股份數量爲131,105,171股,佔其所持股份比例爲98.85%。小貝大美控股向金華市中級人民法院(簡稱“金華中院”)提出的預重整申請尚未被正式受理,小貝大美控股後續實施重整程序,可能導致其在公司的股東權益發生調整。
公司具有獨立完整的業務及自主經營能力,在業務、人員、資產、機構、財務等方面與控股股東相互獨立。小貝大美控股的上述事項不會對公司日常生產經營產生重大影響。公司的生產經營情況正常。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.